Harshvardhan Tevethia

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Model for End-Stage Liver Disease-Lactate and Lactate Clearance in Critically Ill Cirrhosis Patients With Sepsis
  American Journal of Gastroenterology 2026 DOI: 10.14309/ajg.0000000000003934
  +Save
• A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]
  Journal of Hepatology 2022 DOI: 10.1016/j.jhep.2022.03.043
  +Save
• Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study
  Scientific Reports 2022 DOI: 10.1038/s41598-022-09505-1
  +Save
• Prophylactic Perioperative Terlipressin Therapy for Preventing Acute Kidney Injury in Living Donor Liver Transplant Recipients: A Systematic Review and Meta-Analysis
  Journal of Clinical and Experimental Hepatology 2022 DOI: 10.1016/j.jceh.2021.06.019
  +Save
• Use of thiopurines in inflammatory bowel disease: an update
  Intestinal Research 2022 DOI: 10.5217/ir.2020.00155
  +Save
• Midodrine Improves the Tolerability of Diuretics in Patients with Acute-on-Chronic Liver Failure—A Pilot Study
  Journal of Clinical and Experimental Hepatology 2021 DOI: 10.1016/j.jceh.2020.12.002
  +Save
• Efficacy and safety of obeticholic acid in liver disease—A systematic review and meta-analysis
  Clinics and Research in Hepatology and Gastroenterology 2021 DOI: 10.1016/j.clinre.2021.101675
  +Save